Hemo Organic Ltd

Hemo Organic Limited on Saturday, October 3, 2026, approved alterations to its Memorandum of Association, including changes to its main objects to cover activities related to diamonds, real estate, and investments, and increased its authorized share capital from Rs 13.45 crore divided into 13.45 million equity shares to Rs 125 crore divided into 12.5 million equity shares. The company also appointed Pratibha Sharma as Company Secretary and Compliance Officer, effective October 3, 2026, while deferring a proposal for fundraising to a future board meeting.

Hemo Organic Limited will hold a board meeting on Saturday, October 3, 2026, to consider a proposal for raising funds in one or more tranches through the issue of equity shares and/or convertible securities, including convertible warrants, by various methods such as preferential allotment or a qualified institutions placement, subject to statutory and regulatory approvals. The company’s trading window will be closed from September 29, 2026, until 48 hours after the declaration of financial results for the quarter and half year ended September 2026.

Hemo Organic Limited informed the BSE Limited that the trading window for dealing in Equity Shares of the company by insiders, designated persons, and their immediate relatives will be closed from Thursday, October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026.

Hemo Organic Limited announced the allotment of 34,00,000 fully paid-up equity shares following the conversion of an equal number of convertible warrants, as per regulations of the Securities and Exchange Board of India. The allotment, made to Vacro Enterprises Private Limited and Qmin Realities Private Limited, involved a consideration of Rs 12.50 per share, with a premium of Rs 2.50, and aggregated to Rs 3,18,75,000 received in two tranches. Consequently, the company’s paid-up equity share capital increased from Rs 3,46,59,000 to Rs 6,86,59,000.

Hemo Organic Limited announced that its board approved the allotment of 34,00,000 fully paid-up equity shares following the conversion of an equal number of convertible warrants, with a face value of Rs 10.00 each, at an issue price of Rs 12.50 per share. The allotment, made to Vacro Enterprises Private Limited and Qmin Realities Private Limited, involved the receipt of Rs 3,18,75,000 in one or more tranches, increasing the company’s paid-up equity share capital from Rs 3,46,59,000 to Rs 68,65,9000.

Hemo Organic Limited announced that Mr. Dineshbhai Shanabhai Patel and Mrs. Sonalben Dineshbhai Patel, promoters of the company, have entered into share purchase agreements dated September 22, 2026, to sell a total of 5,67,958 fully paid-up equity shares, representing 16.38% of the company's equity and 8.27% on a fully diluted basis, to various buyers including Mrs. Ketanaben Jasani, Mrs. Heema Makadia, M/s. V9BIZ Business Solution LLP, and Jasani Family Trust.

Hemo Organic Limited informed the BSE Limited that the meeting of the Board of Directors scheduled for Wednesday, September 23, 2026, has been cancelled due to unavoidable reasons, as previously intimated on September 19, 2026, under Regulation 29 of SEBI (LODR) Regulations, 2015.

Hemo Organic Limited will seek shareholder approval to raise funds in one or more tranches through the issue of equity shares and/or convertible securities, including convertible warrants, via methods such as preferential allotment, private placement, or public issue, according to a regulatory filing with the BSE Limited on September 19, 2026. The company’s trading window will be closed from the end of business hours on September 19, 2026, until 48 hours after the conclusion of the board meeting scheduled for September 23, 2026.

Hemo Organic Limited informed the BSE that its board of directors approved the receipt of a second tranche of consideration amounting to Rs 2,76,25,000 from allottees in the “Non-Promoter” category for convertible warrants, as detailed in Annexure-1, which includes Vacro Enterprises Private Limited and Qmin Realities Private Limited. The company stated that upon full conversion of the 34,00,000 outstanding warrants, its equity share capital will increase from Rs 3,46,59,000 comprising 34,65,900 shares to Rs 6,86,59,000 comprising 68,65,900 shares.

Hemo Organic Limited announced that members approved the appointment of M/s. V S S B & Associates as the Statutory Auditor for a term of five years, effective from the conclusion of the 34th Annual General Meeting held on September 9, 2026, replacing M/s M A A K & Associates, whose second term concluded at the same meeting.